KU Leuven’s Biosensors group develops first label-free assay characterizing COVID-19 antibodies directly in patient blood, using FOx BIOSYSTEMS platformThe White FOx FO-SPR instrument can rapidly analyze antibody kinetic profiles against SARS-CoV-2 spike proteins in serum and whole blood from COVID-19 patients.